Small Cap Stocks To Watch Now – April 1st

Cyclerion Therapeutics, Direxion Daily MU Bull 2X Shares, AltC Acquisition, Direxion Daily PLTR Bear 1X Shares, and Predictive Oncology are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations, typically in the range of about $300 million to $2 billion. They often offer higher growth potential but also greater volatility and liquidity risk than larger-cap stocks, and exact size cutoffs vary by index and fund manager. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Cyclerion Therapeutics (CYCN)

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc.

Direxion Daily MU Bull 2X Shares (MUU)

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Direxion Daily PLTR Bear 1X Shares (PLTD)

Predictive Oncology (AGPU)

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation.